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Integrin α11β1Protein post-translational modiﬁcations like glycation, carbamylation and citrullination increase the functional
diversity of the proteome but in disease situations might do more harm than good. Post-translational modiﬁca-
tions of ECM proteins are thus appearing as mechanisms, which contribute to tissue dysfunction in chronic
kidney disease, in diabetes and in various inﬂammatory diseases. In chronic renal failure, carbamylation could
lead to kidney ﬁbrosis. In diabetes, high glucose levels lead to non-enzymatic glycation and cross-linking of
collagens, which contribute to tissue stiffening with consequences for cardiovascular and renal functions. In
inﬂammatory diseases, citrullination deiminates arginine residues with possible consequences for integrin-
mediated cell adhesion to RGD- and GFOGER sequences in ECM proteins. Citrullination of ﬁbronectin was in
one study suggested to affect cell adhesion bymodifying theheparin-binding site andnot the RGD site. In a recent
publication citrullination of GFOGER sequences in collagen II was demonstrated to selectively affect α10β1 and
α11β1 integrin-mediated cell adhesion to collagen II, with consequences for synovial ﬁbroblast and stem cell ad-
hesion and migration. The implications of citrullination affecting integrin binding in disease open up a new area
of study andmight have implications for the pathogenesis of inﬂammatory diseases like rheumatoid arthritis and
periodontitis.
© 2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Glycation, citrullination and carbamylation are three post-
translational modiﬁcations that can change the interacting properties
of proteins containing lysine and arginine in their interactive domains
(Fig. 1).ECM, extracellular matrix; CKD,
nase; PAD, peptidyl-arginine
e; RA, rheumatoid arthritis.
ullberg).
pen access article under the CC BY-NThinking about these post-translational modiﬁcations from amatrix
perspective, ECM proteins like ﬁbronectin and collagens represent
targets where post-translational changes can potentially affect cell
adhesion, physicochemical properties and antigenicity.
A major group of cell surface receptors for the ECM are integrins
(Barczyk et al., 2010). Whereas substantial data has been collected on
how integrins interact with other signaling receptors to integrate extra-
cellular information (Legate et al., 2009), less is known about how
integrins actually interact with their ligands in vivo.
Questions that need to be considered include details of how ligand
organization, availability and post-translational modiﬁcations change
the ability of integrins to bind ligand. A recent study suggests that
citrullination of collagen II affects integrin binding and implies integrinsC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. ECMpost-translationalmodiﬁcations and their involvement in disease. Biochemical reactions of glycation (A), carbamylation (B) and citrullination (C) are depicted. PADs: peptidyl-
arginine deiminases. D.With an increase of glucose concentration, glycation of collagen I induces differentiation of cardiac ﬁbroblasts intomyoﬁbroblasts, via autocrine secretion of TGF-β2
(Talior-Volodarsky et al., 2012). E. Carbamylation of collagen I impaired inﬂammatory cell functions like respiratory burst (Jaisson et al., 2007). Carbamylation can also promote
autoimmune response leading to arthritis (Shi et al., 2014).
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2014). In relation to this publication we provide a short summary of
citrullination with a brief overview on glycation and carbamylation
since these are post-translational modiﬁcations that affect the same
amino acids, and make the link to diseases other than arthritis.
1.1. Mechanisms of extracellular post-translational modiﬁcations and their
consequences for cell–matrix interactions
Glycation is the non-enzymatically covalent reaction whereby
reducing sugars like glucose form bonds to amino groups in amino
acids like lysine and arginine (Bucala and Cerami, 1992). Glycated colla-
gen can then form non-enzymatic crosslinks known as advanced
glycation end-products (AGEs) (Gautieri et al., 2014). The involvement
of integrins in biological effects of glycation and AGEs needs further
study, but studies so far indicate that glycation interfereswith cell adhe-
sion to collagen I (Avery and Bailey, 2006;McCarthy et al., 2004; Morita
et al., 2005).
Carbamylation leads to the non-enzymatic addition of urea-derived
isocyanic acid to α-NH2 (protein N-termini) and ε-NH2 (lysine
residues), and has been shown to affect collagen I triple helix stability
and sensitivity to MMP cleavage (Jaisson et al., 2007). Available datasuggest that carbamylation does not primarily affect cell adhesion
since lysine residues are not present in cell adhesive sequences used
by integrins. However, carbamylation could induce the structure modi-
ﬁcation of ECM proteins that may result in the lack of recognition by
integrins (Jaisson et al., 2006).
On the contrary, citrullination is an enzymatic process that thus
differs from glycation and carbamylation by physiological roles.
Citrullination contributes to distinct functions such as skin protection
and gene regulation by affecting keratin and histones, respectively.
Hypercitrullination of histones is also involved in immune responses,
essential in the formation of highly decondensed chromatin structures
(Baka et al., 2012). Citrullination requires enzymes called peptidyl-
arginine deiminases (PADs), which act to replace the primary ketimine
group (_NH) by a ketone group (_O). PADs are intracellular enzymes
and belong to a family of 5 members in humans, PAD 1–4 and PAD-6
(Yoshida et al., 2006). Under some conditions like inﬂammation, the
enzymes can be released into the extracellular space. PAD-4 expressed
by neutrophils is considered to be a major enzyme involved in extracel-
lular citrullination in inﬂammation. Citrullination, leads to deimination
of arginine and has the potential to modify cell adhesive properties of
proteins containing the RGD sequence (ﬁbronectin, ﬁbrinogen) and
GFOGER-like sequences (collagens). Citrullination has been observed
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et al., 2012), although, somewhat surprisingly, no direct link to the
RGD site was demonstrated in that study, but instead suggesting that
arginines in the heparin-binding domain are the targets of citrullination
in ﬁbronectin. The molecular mechanism of cell adhesion to collagen
has long been a subject of controversy (Zeltz et al., 2014). In vitro exper-
iments have convincingly established that cells using β1 integrin recep-
tors bind directly to GFOGER sequences in monomeric triple helical
collagens (Carafoli et al., 2013; Emsley et al., 2000; Farndale et al.,
2008; Knight et al., 2000; Zhang et al., 2003) and indirectly to RGD-
sites in COLINBRIs using β1- and αv-integrins (Reyhani et al., 2014;
Zeltz et al., 2014).
1.2. Post-translational modiﬁcations of ECM in disease
Collagens are non-enzymatically glycated not only during diabetes
with increased levels of glucose but also during aging, leading to in-
creased tissue stiffness (Gautieri et al., 2014), which is suggested to be
a pathophysiological factor in renal, cardiac, and blood vessel dysfunc-
tion (Willemsen et al., 2012). Interestingly, in diabetic cardiomyopathy,
myoﬁbroblast differentiation is induced by glycated collagen I, in a
mechanism that seems to involve integrin α11β1-mediated autocrine
secretion of TGF-β2 (Talior-Volodarsky et al., 2012) (Fig. 1D).
In vitro experiments and clinical studies have suggested the potential
involvement of carbamylated proteins in chronic kidney disease (CKD)
complications like atherosclerosis. A recent study in a mouse model
demonstrates that the chronic increase of urea, as seen in CKD,
increases the carbamylation rate of plasmaand tissue proteins, including
collagens (Pietrement et al., 2013). Lysine carbamylation could induce
autoimmune response via production of anti-homocitrulline antibodies,
leading to arthritis (Jaisson et al., 2011) (Fig. 1E).
Citrullination occurs in rheumatoid arthritis (RA) and antibodies to
citrullinated proteins are found in several inﬂammatory diseases
(Makrygiannakis et al., 2006). An interesting link exists between
citrullination, rheumatoid arthritis and periodontitis (PD). Subjects
with PD are at an increased risk to develop RA, and vice versa. Current
ﬁndings support the idea that PD could be a factor in the initiation of
autoimmune inﬂammatory responses that occur in RA. The citrullination
in periodontitis may lead to the breaking of immunotolerance
to citrullinated proteins, contributing to the development of RA
(Koziel et al., 2014). The leading pathogen in chronic periodontitis,
Porphyromonas gingivalis, produces a bacterial enzyme, P. gingivalis
peptidyl-arginine deiminase (PPAD). In support of a role of this enzyme
in the development of arthritis, inoculation of animals with a PPAD
knockout P. gingivalis strain prior to immunization with collagen II had
no inﬂuence on clinical development or progression of the experimental
arthritis (Maresz et al., 2013). This is in contrast to mice that had been
inoculated with a wildtype PPAD producing P. gingivalis strain and
where collagen II-induced arthritis was exacerbated by infection with
the periodontal pathogen. In addition, in amodel for experimental auto-
immune arthritis antibodies against citrullinated proteins have been
found to be pathogenic (Kuhn et al., 2006).
2. An unexpected role casting in the synovium- or what a difference
an imine group makes
An interesting study by Sipila et al. asks the question if citrullination
of collagen II affects cell adhesion by modifying the GFOGER sequence
(Sipila et al., 2014). The answer is yes. However, a systematic compari-
son of the binding of the four β1 integrin collagen receptors, α1β1,
α2β1, α10β1 and α11β1, somewhat surprisingly reveals that it is
mainly the binding of α10β1 and α11β1 to collagen II that is affected
by citrullination. A modest decrease in cell migration mediated by
these receptors on citrullinated collagen II is also observed. The authors
suggest that the reduced cell adhesion might interfere with the migra-
tion of synovial ﬁbroblasts and mesenchymal stem cells in vivo.Why is it surprising that the chondrocyte α10β1 and ﬁbroblasts
α11β1 are identiﬁed in these assays?
1. α1β1 and α2β1 have been studied in the context of cartilage and
bone in a limited number of studies, but were still prior to this
study the main candidate collagen receptors to be affected by colla-
gen citrullination. Since both α1β1 and α2β1 are expressed on in-
ﬂammatory cells and mesenchymal stem cells, one could envision
that reduced cell adhesion due to citrullination would affect inﬂam-
matory cell adhesion in the inﬂamed synovia. However, this does
not appear to be a likely scenario. Instead the results from Sipila
et al. suggest that α10β1 and α11β1 play leading roles on non-
immune cells in the synovia.
2. .It is maybe not so surprising that citrullination affects GFOGER-de-
pendent cell adhesion to collagen II, but themore surprising is the se-
lective effect for two of the four collagen-binding integrins, although
all four collagen receptors bind the GFOGER sequence. The reason for
this can be understood in structural terms. A comparison of the
atomic structure of the four I domains interacting with a trimeric
GFOGER peptide reveals that α10 - and α11 I-domains interact
with the charged arginine in GFOGER in uncitrullinated collagen.
The arginine is sandwiched between two negative residues in the
α10- andα11 I-domains. For integrin binding to the citrullinated col-
lagen, there is no charge neutralization for α10β1- and α11β1-
mediated binding, resulting in a weaker interaction.
The study is important since it explains the effect of citrullination of
collagen II at the molecular level, however a number of questions
remain unanswered.
– α11β1 is expressed on cultured mesenchymal stem cells, but it will
be important to determine if this expression also extends to the
mesenchymal stem cells in joints in vivo.
– α10β1 and α11β1 are expressed on chondrocytes and synovial
ﬁbroblasts, respectively and it will be important to determine
to what extent cells in synovia are in contact with citrullinated
collagen II.
– Since collagens form ﬁbrillar structures, it is unclear to what extent
the integrin-binding GFOGER sequences are available to cells in
mature cartilage and synovia matrices in vivo. It is possible that the
availability of GFOGER for extracellular citrullination is largely re-
stricted to dynamic situations where ECM is turned over and
GFOGER motifs are exposed (Zeltz et al., 2014).
– α11β1 is normally found in cells residing in matrices rich in
collagen I, so the question arises if citrullination of collagen I also
occurs in the synovial membrane and has the same effect as that
observed when collagen II is citrullinated.
– Sinceα11β1 is also expressed in human periodontal ligament ﬁbro-
blasts (Barczyk et al., 2009, 2013) it would be interesting to establish
if α11β1 has a function in periodontal disease in the context of
citrullination. Maybe a reduced adhesion of periodontal ligament
ﬁbroblasts to the periodontal collagen I will contribute to a disorga-
nized matrix more susceptible to inﬂammatory cell destruction.
– To test if the ﬁndings have an effect as suggested by the authors it
would be important to show proof of principle in animal models.
Some of the issues raised above are schematically summarized in
Fig. 2.
3. Conclusion
In summary, the recent ﬁndings of post-translational modiﬁcations
of cell adhesion sites in ECM proteins open up a new ﬁeld of study.
Citrullination appears to be an important mechanism in inﬂammatory
disease and with a possible link to integrin-mediated adhesion we will
surely hear more about this subject in the future.
Fig. 2. Schematic view of the potential role of citrullinated collagen in periodontitis and in the arthritic synovium. A. Schematic representation of the potential role of citrullination in
periodontitis. Human periodontal ligament in normal uninﬂamed state (a) and inﬂamed state (b) is shown. Bacterial P. gingivalis peptidyl-arginine deiminase (PPAD) is suggested
to citrullinate collagen I to affect integrin α11β1-mediated interactions with collagen I. B. Schematic representation of normal synovium (a) and arthritic synovium (b) is shown. For
simplicity only cells expected to express integrin α10β1 (chondrocytes) and integrin α11β1 (synovial mesenchymal stem cells and synovial ﬁbroblasts) are depicted. Neutrophil-
released peptidyl-arginine deiminases (PADs) are suggested to citrullinate collagen II in cartilage.
Modiﬁed from Smolen and Steiner (2003).
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